Reduction in hospitalizations following initiation of amikacin liposome inhalation suspension: A retrospective cohort study of patients in real-world settings

Reduction in hospitalizations following initiation of amikacin liposome inhalation suspension: A retrospective cohort study of patients in real-world settings

Abstract RATIONALE Mycobacterium avium complex (MAC) lung disease (LD) is a rare infectious disease with substantial disease burden, high rates of hospitalizations, and where 20% to 40% of patients do not respond to prescribed treatments. In 2018, amikacin liposome...